123 related articles for article (PubMed ID: 36974822)
1. EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation.
Ganesh D; Dafar A; Niklasson J; Sandberg I; Braz-Silva P; Sapkota D; Öhman J; Giglio D; Hasséus B
Anticancer Res; 2023 Apr; 43(4):1533-1542. PubMed ID: 36974822
[TBL] [Abstract][Full Text] [Related]
2. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
[TBL] [Abstract][Full Text] [Related]
3. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
4. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
6. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
7. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
8. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.
Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA
Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289
[TBL] [Abstract][Full Text] [Related]
9. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
12. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
15. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
16. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
[No Abstract] [Full Text] [Related]
17. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
19. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
20. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]